JUST IN　•　WIRED

Finding New Drugs Is Laborious. This AI Startup Is Skipping The Lab Work

SHARE THIS STORYPLUS UNLOCKS FAVORITES READ LATER AND SOURCE CONTROL

Potential Sciences, a startup backed by the UK government, is betting that training AI models on computer-generated biochemical data can speed up the plodding process of developing new drugs.

READ ORIGINAL REPORT ↗

THIS JUST HAPPENED PACKAGES THE WORLD INTO A FAST LIVE FEED SOURCE REPORTING STAYS ONE CLICK AWAY

RELATED POSTSMORE BUSINESS

BUSINESS　•　MarketWatch.com - Top Stories

Qualcomm’s stock falls as twin forces pressure sales

BUSINESS　•　BBC News

Why do veterinary fees and sausage rolls vary in price across London?

BUSINESS　•　News | Euronews RSS

North Korea tells EU to 'mind its own business' after draft UN resolution on human rights

BUSINESS　•　BBC News

Finding New Drugs Is Laborious. This AI Startup Is Skipping The Lab Work

Qualcomm’s stock falls as twin forces pressure sales

Why do veterinary fees and sausage rolls vary in price across London?

North Korea tells EU to 'mind its own business' after draft UN resolution on human rights

Drunk and dangerous e-bike riders face on-the-spot fines under crackdown

Second buyer makes rescue bid for Poundland as retailer faces collapse

Russia plans ticket surcharge to bankroll struggling aircraft industry

Poundland owner in crunch talks as retailer's collapse looms

Pound rises to its highest level since the Brexit referendum